QualityStocks'  Instablog

Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • UV Flu Technologies, Inc. (UVFT) Board Approves Pursuit Of RxAir Spinoff 0 comments
    Jun 21, 2013 1:37 PM | about stocks: UVFT

    UV Flu Technologies, a developer, manufacturer, and distributor of biotech products for the Indoor Air Quality sector, said it plans to pursue the spinoff of its RxAir business into a separate publicly traded entity. Upon closing of the transaction, RxAir division will assemble a separate management team and board of directors to guide the company's air purification services and offerings to the medical and commercial markets. UVFT will continue to concentrate on the residential marketplace.

    "RxAir will include the medical market, which will encompass the Sleep marketplace, including sleep centers and hospitals, clinics and nursing homes. In addition RxAir will include the commercial market, which will include casinos, salons, restaurants, government buildings and military installations," Jack Lennon, UVFT CEO, stated in the press release. "RxAir has an installed base in over 600 hospitals in several countries, along with numerous commercial accounts, we think the platform for focused growth, for both entities, will dramatically enhance shareholder value."

    RxAir will have five products, with its patented, FDA-cleared HEPA air purifier, the RX-3000; the RxAir Plus System, which utilizes two FDA-cleared technologies; and the RX-4500, RX-6500, and RX-400. UVFT will have its flagship patented UV air purifier, the ViraTech UV-400, which is an FDA-cleared Class II Medical Device.

    Operating in individual markets and armed with their innovative technologies, Lennon said the spinoff will "unlock the value hidden within each of the two entities to achieve strategic and operational clarity."

    The transaction will be structured as a pro rata distribution to all shareholders of UVFT, with the holders of its common stock receiving additional common stock in RxAir. Upon closing of the proposed spinoff, UVFT's existing shareholders would hold interests in both UVFT and RxAir.

    In upcoming months, management of both companies will develop detailed plans for UVFT's board of director's further consideration and final approval.

    For more information visit uvflutech.com or rxair.com

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

    Stocks: UVFT
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.